Use of BMP in Spinal Fusion Surgery Linked to More Complications Higher Costs Medscape
A new study shows that use of bone-morphogenetic protein (BMP) to promote bone growth in spinal-fusion surgery is associated with a higher rate of complications and higher hospital costs than surgeries where it is not used.
The researchers, led by Kevin S. Cahill, MD, PhD, from the department of neurosurgery at Brigham and Women's Hospital, in Boston, Massachusetts, conclude that their report "highlights the robust nationwide application of BMP in spinal-fusion procedures in the first 5 years of clinical usage since [Food and Drug Administration] FDA approval.
"The effects on complication occurrence in anterior cervical fusions, as well as the increases in length of stay and hospital charges, illustrate the need to continue to develop refined guidelines for usage and to further study the long-term risks and benefits of usage," they write.
Their findings are published in the July 1 issue of the Journal of the American Medical Association.
Type: Reference Material
Author/Contact: Not Available
Submitted by: admin
Added: Wed Jul 22 2009